Le Lézard
Classified in: Health, Science and technology
Subject: Event

ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting


ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced final overall survival data and an evaluation of sequence of therapy in the pivotal SORAYA trial of mirvetuximab soravtansine in patients with folate receptor alpha-high platinum-resistant ovarian cancer who had been previously treated with bevacizumab will be presented by Dr. Robert Coleman in a plenary session on Saturday, March 25, at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting in Tampa, Florida.

Oral Presentation Details
Title: Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Evaluation of Sequence of Therapy on Anti-Tumor Activity in the SORAYA Study
Session: Scientific Plenary I: Progress: Therapeutics Innovations
Session Date: Saturday, March 25, 2023
Session Time: 9:00 am to 10:30 am ET

Additional information can be found at www.sgo.org.

ABOUT IMMUNOGEN
ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOWtm.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.


These press releases may also interest you

at 19:41
Valor Healthcare Awarded Contract to Provide Remote Patient Monitoring Services for the U.S. Department of Veterans Affairs
Valor Healthcare is proud to announce its selection as one of four companies awarded a position on Veterans Affairs' (VA) eight-year, $1.032 billion contract to provide Remote Patient Monitoring (RPM) and Home Telehealth (HT) services for veterans....

at 19:37
Reaction to the tabling of Bill 32: First Nations must be at the heart of and guide the approach to cultural safety within the Quebec health and social services network
While the Assembly of First Nations Quebec-Labrador (AFNQL) and the First Nations of Quebec and Labrador Health and Social Services Commission (FNQLHSSC) welcome some of the proposed advances, they are expressing disappointment following the tabling,...

at 19:00
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa
Pursuant to the signing of a Letter of Intent (LOI) in December 2022, Asep Medical Holdings Inc. ("Asep Inc." or the "Company") is delighted to announce it has signed a definitive agreement ("agreement") for a joint venture with Bahrain-based...

at 18:45
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer's disease The PDUFA action date for traditional approval of...

at 18:30
Global Medical Display Market to 2028 - Growing Demand for Digital Healthcare Fuels the Sector
The "Global Medical Display Market by Technology (LED-Backlit LCD Displays, CCFL-Backlit LCD Displays, OLED Displays), Panel Size (Under 22.9 inch panels, 23.9-26.9 inch panels, 27-41.9 inch panels), Resolution, Display Color, Application - Forecast...

at 18:15
Global Human Microbiome Market Report 2023: Sector is Projected to Reach $1.7 Billion by 2029 at a CAGR of 36.1%
The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT), and Region - Forecast to 2029"...

More news about Health...


News published on and distributed by: